Related Experiment Video
Updated: Jun 5, 2026

Studying Adipose Endothelial Cell/Adipocyte Cross-Talk in Human Subcutaneous Adipose Tissue
Published on: April 5, 2024
Environmental risk conditions and pathways to cardiometabolic diseases in indigenous populations
Mark Daniel1, Peter Lekkas, Margaret Cargo
1Social Epidemiology and Evaluation Research Unit, Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia. mark.daniel@unisa.edu.au
Abstract:
This review examines environments in relation to cardiometabolic diseases in Indigenous populations in developed countries. Environmental factors are framed in terms of context (features of places) and composition (features of populations). Indigenous peoples are seen to have endured sociopolitical marginalization and material disadvantage spanning generations. Past adverse collective experiences, modified by culture, are reflected by current heterogeneity in environmental context and composition. As risk conditions, unfavorable contextual and compositional exposures influence the expression of cardiometabolic risk for individuals. Minimal research has evaluated heterogeneity in risk conditions against heterogeneity in cardiometabolic diseases between or within Indigenous populations. Thus far, the features of populations, not of places themselves, have been implicated in relation to cardiometabolic diseases. Behavioral, psychosocial, and stress-axis pathways may explain the relationships between risk conditions and cardiometabolic diseases. Implications of environmental factors and their pathways as well as important research needs are discussed in relation to ecological prevention to reduce cardiometabolic diseases.
Related Concept Videos
Coronary Artery Disease I: Introduction
Type II Diabetes I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Coronary Artery Disease IV: Preventive Measures
Drug Toxicity: Risk factors
